Product Name | MF | CAS | Details |
---|
Crisaborole Impurity 28 | C7H5BrO2 | 196081-71-7 | Details |
Crisaborole Impurity 27 | C7H5BrO2 | 20035-32-9 | Details |
Aprepitant Impurity 66 | C8H19NO5 | 76326-99-3 | Details |
Apixaban Impurity 69 | C8H11NO | 156-43-4 | Details |
heptane | C7H16 | 142-82-5 | Details |
1,2-dichloropropane | C3H6Cl2 | 78-87-5 | Details |
Dexmedetomidine Impurity 2 | C9H10O | 5779-93-1 | Details |
Ezetimibe Impurity 97 | C11H11FO3 | 199664-70-5 | Details |
heptan-3-one | C7H14O | 106-35-4 | Details |
Empagliflozin Impurity 69 | C6H12O6 | 7660-25-5 | Details |
dipropylamine | C6H15N | 142-84-7 | Details |
hexane | C6H14 | 110-54-3 | Details |
ethyl hydrogen sulfate | C2H6O4S | 540-82-9 | Details |
2-(dimethylamino)ethyl methacrylate | C8H15NO2 | 2867-47-2 | Details |
ethanol | C2H6O | 64-17-5 | Details |
Guanfacine hydrochloride Impurity 3 | C8H6Cl2O2 | 6575-24-2 | Details |
3-hydroxybutan-2-one | C4H8O2 | 513-86-0 | Details |
Diethylcarbamazine citrate EP Impurity B | C6H14N2 | 106-58-1 | Details |
Dopamine Impurity 25 | C8H10O2 | 1124-39-6 | Details |
Gadobutrol Impurity 43 | C7H12O3 | 57280-22-5 | Details |
ethyl propionate | C5H10O2 | 105-37-3 | Details |
Dobutamine Impurity 27 | C10H11NO2 | 93-17-4 | Details |
Cefazolin Impurity 34 | C6H8ClNO4 | 66338-95-2 | Details |
Flunarizine Impurity 12 | C9H10Cl2 | 14155-36-3 | Details |
glutaraldehyde | C5H8O2 | 111-30-8 | Details |
1-ethoxybutane | C6H14O | 628-81-9 | Details |
Eltrombopag Impurity 55 | C8H12N2 | 13636-53-8 | Details |
1,2-Dinitroglycerin | C3H6N2O7 | 621-65-8 | Details |
Ivabradine Impurity 60 | C10H12O4 | 93-40-3 | Details |
hexan-2-ol | C6H14O | 626-93-7 | Details |
3,5-dimethylaniline | C8H11N | 108-69-0 | Details |
ethyl carbamimidate | C3H7NO2 | 51-79-6 | Details |
3,5-dimethylpyridine | C7H9N | 591-22-0 | Details |
heptan-4-one | C7H14O | 123-19-3 | Details |
hexan-1-amine | C6H15N | 111-26-2 | Details |
N1,N1-dimethylpropane-1,3-diamine | C5H14N2 | 109-55-7 | Details |
3-ethoxyaniline | C8H11NO | 621-33-0 | Details |
fluorobenzene | C6H5F | 462-06-6 | Details |
formic acid | CH2O2 | 64-18-6 | Details |
N-ethyl-N-isopropylpropan-2-amine | C8H19N | 7087-68-5 | Details |
Cabozantinib Impurity 62 | C12H10N2O2 | 2050-16-0 | Details |
3-Fluorotoluene | C7H7F | 352-70-5 | Details |
Ivabradine Impurity 84 | C11H16ClNO2 | 1132079-01-6 | Details |
diisobutyl phthalate | C16H22O4 | 84-69-5 | Details |
1,1-diethoxyethane | C6H14O2 | 105-57-7 | Details |
diisopropylamine | C6H15N | 108-18-9 | Details |
2-iodopropane | C3H7I | 75-30-9 | Details |
2-ethoxyaniline | C8H11NO | 94-70-2 | Details |
Avanafil Impurity 70 | C8H19N3O | 32897-26-0 | Details |
Dembrexine hydrochloride EP Impurity D | C7H6O2 | 90-02-8 | Details |
1-ethylpiperidine | C7H15N | 766-09-6 | Details |
1,4-dioxane | C4H8O2 | 123-91-1 | Details |
Apremilast Impurity 78 | C10H11NO2 | 60758-86-3 | Details |
ethyl 2,2,2-trifluoroacetate | C4H5F3O2 | 383-63-1 | Details |
1,1-dichloroethane | C2H4Cl2 | 75-34-3 | Details |
2-ethylbutan-1-ol | C6H14O | 97-95-0 | Details |
isothiocyanatomethane | C2H3NS | 556-61-6 | Details |
Cabozantinib Impurity 59 | C5H8O4 | 1071-46-1 | Details |
Emtricitabine Impurity 34 | C4H6Cl2S2 | 13405-87-3 | Details |
2,5-dimethylbenzenethiol | C8H10S | 4001-61-0 | Details |
Nicorandil Impurity 23 | C2H5NO3 | 625-58-1 | Details |
ethyl 2-bromoacetate | C4H7BrO2 | 105-36-2 | Details |
2,6-dimethylpyridine | C7H9N | 108-48-5 | Details |
N,N-dimethylaniline | C8H11N | 121-69-7 | Details |
(2-hydroperoxypropan-2-yl)benzene | C9H12O2 | 80-15-9 | Details |
ethyl acetate | C4H8O2 | 141-78-6 | Details |
2,4-dimethylaniline | C8H11N | 95-68-1 | Details |
p-Fluorotoluene | C7H7F | 352-32-9 | Details |
Ezetimibe Impurity 90 | C16H19FO4 | 1056188-47-6 | Details |
dimethylcarbamic chloride | C3H6ClNO | 79-44-7 | Details |
N,N-diphenylnitrous amide | C12H10N2O | 86-30-6 | Details |
Cefpodoxime Proxetil Impurity 22 | C6H11IO3 | 84089-73-6 | Details |
1,1-dichloropropan-2-one | C3H4Cl2O | 513-88-2 | Details |
1,2-dihydroacenaphthylene | C12H10 | 83-32-9 | Details |
Nicorandil Impurity 24 | C2H6N2O2 | 98033-27-3 | Details |
4-Fluoroaniline | C6H6FN | 371-40-4 | Details |
Azilsartan Impurity 69 | C5H6O4 | 91526-18-0 | Details |
Ixazomib Impurity 13 | C7H4Cl2O | 6334-18-5 | Details |
Dolasetron impurity 2 | C8H7N | 120-72-9 | Details |
1,1-dichloroethene | C2H2Cl2 | 75-35-4 | Details |
dipentylamine | C10H23N | 2050-92-2 | Details |
2-Fluorotoluene | C7H7F | 95-52-3 | Details |
3-(1H-imidazol-4-yl)acrylic acid | C6H6N2O2 | 104-98-3 | Details |
Diethyl carbonate | C5H10O3 | 105-58-8 | Details |
N,N-diethylaniline | C10H15N | 91-66-7 | Details |
ethyl isobutyrate | C6H12O2 | 97-62-1 | Details |
Glyceryl monolinoleate | C21H38O4 | 26545-74-4 | Details |
iodoethane | C2H5I | 75-03-6 | Details |
3-ethylhexane | C8H18 | 619-99-8 | Details |
Dopamine Impurity 22 | C8H7NO2 | 3131-52-0 | Details |
dimethoxymethane | C3H8O2 | 109-87-5 | Details |
Dabigatran Etexilate Impurity 23 | C7H13ClO2 | 58906-64-2 | Details |
Cabozantinib Impurity 23 | C6H6FNO | 406-00-8 | Details |
Apixaban Impurity 136 | C4H6Cl2O2 | 18017-35-1 | Details |
4-hydroxy-4-methylpentan-2-one | C6H12O2 | 123-42-2 | Details |
2-ethylpyridine;Dimetindene maleate EP Impurity A | C7H9N | 100-71-0 | Details |
ethyl 2-chloroacetate | C4H7ClO2 | 105-39-5 | Details |
ethyl 2-cyanoacetate | C5H7NO2 | 105-56-6 | Details |
2,5-dimethylaniline | C8H11N | 95-78-3 | Details |
ethenone | C2H2O | 463-51-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 |